NHS Genomics Hub Tests for New Anti-Cancer Drug Variant
Routine genetic testing to guide use of chemotherapy has incorporated a new “African” gene variant which could potentially help save the lives of Black and ethnic minority cancer patients.
Latest
Comment and analysis on key issues on ethnic health inequalities in health and social care.
New Online Health Hub To Tackle Inequalities in Genomic Healthcare
A strategic partnership with the NHS North Thames Genomic Medicine Service (NT GMS) designed to ensure better access, understanding and information to genomic medicine and research has been announced by the NHS Race and Health Observatory.
Statement in response to the Government announcement on DNA testing and research
Responding to today’s Government announcement on DNA testing and research, Dr Veline L’Esperance, Senior Clinical Advisor to the Observatory, said:
Review to explore cancer drug limitations due to ethnic gene variations
Wider genetic testing could save lives, reduce costs and help thousands of Black, Asian and ethnic minority patients at risk of severe side effects resulting from chemotherapy drugs.
Identification and assessment of ethnic health inequalities that exist within the Genomic Medicine Service
The NHS Genomic Medicine Service was commissioned in October 2018 by NHS England.